番茄社区app

Cardiology >

Myocardial Infarction

News, opinions and meeting coverage in cardiology.

COPD Tied to Higher MI Risk in HIV-Positive People

Higher risk seen for supply-demand mismatch as with sepsis, though mechanisms of association unclear

Biodegradable-Polymer DES Still Not Better Than Durable DES

Data offer a look at what happens after Orsiro sheds its polymer

Mixed Results for AngelMed Guardian in Acute MI Detection

Some value seen in notification of silent MIs

Heavy Workouts Linked to Hard Arteries

But subclinical calcified plaque didn't translate into mortality risk in study

In-Hospital Acute MI Common, Outcomes Poor

Better strategies may be needed, VA study authors suggest

Revascularization for Silent Ischemia Linked to Better Outcomes

Registry suggests much lower MI risk for asymptomatic stable disease

Top-Ranked Hospitals Have Better Survival Rates

U.S. News and World Report rankings not associated with fewer readmissions

Omega-3 and Vitamin D; Vein Grafts and CABG: It's PodMed Double T!

This week's topics include benefits of CABG, vein harvesting, new exercise guidelines, and omega-3 and vitamin D supplementation

Metabolic Surgery Prevails for Mortality, CV-Risk Reduction in T2D

Macrovascular complications, CV mortality reduced more with surgery than medical therapy alone

Biodegradable-Polymer DES No Better at 10 Years

Clinical benefit elusive long after polymer should have disappeared

AHA: Zetia May Cut CV Events in Japanese Seniors

Results from EWTOPIA75 trial not enough to change practice, experts says

AHA: Fish Oil, Vitamin D Not VITAL to Heart Health

VITAL trial also showed no benefits for cancer incidence with both supplements

Expert Panel: Cap Oxygen Saturation at 96% for Acutely Ill Patients

Recommends special caution for stroke, MI patients

FDA Rejects Canakinumab in CVD Prevention

CANTOS data not enough to expand indication

Morning Break: Human Side of Addiction; Eyeing Da Vinci's Genius; No CV Indication for Ilaris

Health news and commentary from around the Web gathered by the 番茄社区app staff

FDA Approves Rivaroxaban for CV Prevention in CAD, PAD

Low dose to arrive in the U.S. next week

Heart Benefit Seen with GLP-1 RA Albiglutide

Significant reduction in myocardial infarctions; will drug be brought back to market?

TCT: IVUS Tops Angiography Guidance for Stent Implantation

Intravascular ultrasound-guidance cut TVF in all-comers trial

TCT: 10 Years On, Surgery for Left Main Disease Edges Stenting

Separate studies suggest some groups do better with CABG

Vascepa Prevents Major Cardiovascular Events, Says Manufacturer

Big win for proprietary fish-oil product

TCT: Studies Suggest Thin May Not Always Be in for DES

Resolute Onyx, BioFreedom on par with ultra-thin Orsiro stent

TCT: Orsiro Stent has Its Day in BIOFLOW V Trial

Does this mean superiority over Xience?

10-Minute Headstart for the Cath Lab Helps in STEMI Emergencies

Quicker revascularization, possibly better survival seen in registry

Pre-Hospital Laryngeal Tube Ups Cardiac Arrest Survival

Trials cast doubt on endotracheal intubation as preferred treatment

ESC: DCB Works for De Novo Stenoses in Small Coronary Vessels

Established for in-stent restenosis, DCBs make their way to native coronary arteries

ESC: ACS Outcomes the Same for High-Sensitivity vs Standard Troponin Tests

No reduction in later events with more sensitive assay

ESC: MI Redefined in International Guidelines

Fourth "Universal Definition of Myocardial Infarction" issued

ESC: Short DAPT with Ticagrelor Doesn't Improve Outcomes

Antiplatelet strategy safe, but misses superiority to standard DAPT after stenting

ESC: CTA for Stable Chest Pain Prevents More MIs Long Term

Better than stress ECG as first-line test, SCOT-HEART investigators say

Cath Lab Recap: Intracardiac Echo; Safe Late Lumen Loss Limit

Interventional cardiology news to note

TAVR Growing Even in Younger Age Groups

National trends seen across ages through 2015 likely have continued

Antidepressant After ACS May Help Long-Term Cardiac Outcomes

Extended trial follow-up shows advantages where prior RCTs have not

Study: Epinephrine May Not Be Best Choice for Cardiogenic Shock in MI

Associated with higher rates of refractory shock than with norepinephrine

Studies on Post-STEMI Tx Seen Marred by Faulty Endpoint

MSI calculated from edema-based AAR problematic, researchers say

Select STEMI Patients Gain Microvascular Boost with Novel Device

Infarct sizes also smaller with PCI add-on

Pilot Study Hints at IABP Benefit for Some STEMI Patients

Trend toward better prognosis in those with persistent post-PCI ischemia

LAMA Tx Didn't Up Heart Disease Risk in COPD

Cardiovascular outcomes similar to placebo-treated patients

Ticagrelor Linked to Sleep Apnea, Dyspnea

Breathing problems particularly common with this particular antiplatelet

Why Call for Doctor on the Plane If They're Just Going to Ignore You?

Milton Packer recounts two very different experiences

Troponin Predicts Mortality in Inflammatory Arthritis

High levels associated with all-cause and cardiovascular death

鈥�

10